Skip to main content

and
  1. Article

    Open Access

    Total genomic alteration as measured by SNP-array-based molecular karyoty** is predictive of overall survival in a cohort of MDS or AML patients treated with azacitidine

    Metaphase cytogenetics (MC) has a major role in the risk stratification of patients with myelodysplastic syndromes (MDSs) and can affect the choice of therapies. Azacitidine (AZA) has changed the outcome of pa...

    T Cluzeau, C Moreilhon, N Mounier, J-M Karsenti, L Gastaud in Blood Cancer Journal (2013)